Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.
Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.
The global Human Coagulation Factor VII market was valued at US$ 2087.1 million in 2020 and is expected to reach US$ 3955.9 million by the end of 2029, growing at a CAGR of 9.6% during 2021-2029.
This report focuses on Human Coagulation Factor VII volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Human Coagulation Factor VII market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Human Coagulation Factor VII Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII
Segment by Application
Hemophilia A
Spontanous / Trauma
Surgical
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
NovoNordisk
1 Human Coagulation Factor VII Market Overview
1.1 Product Overview and Scope of Human Coagulation Factor VII
1.2 Human Coagulation Factor VII Segment by Type
1.2.1 Global Human Coagulation Factor VII Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VII Segment by Application
1.3.1 Global Human Coagulation Factor VII Sales Comparison by Application: (2021-2029)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Others
1.4 Global Human Coagulation Factor VII Market Size Estimates and Forecasts
1.4.1 Global Human Coagulation Factor VII Revenue 2016-2029
1.4.2 Global Human Coagulation Factor VII Sales 2016-2029
1.4.3 Human Coagulation Factor VII Market Size by Region: 2016 Versus 2021 Versus 2029
2 Human Coagulation Factor VII Market Competition by Manufacturers
2.1 Global Human Coagulation Factor VII Sales Market Share by Manufacturers (2016-2021)
2.2 Global Human Coagulation Factor VII Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Coagulation Factor VII Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Coagulation Factor VII Manufacturing Sites, Area Served, Product Type
2.5 Human Coagulation Factor VII Market Competitive Situation and Trends
2.5.1 Human Coagulation Factor VII Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Coagulation Factor VII Players Market Share by Revenue
2.5.3 Global Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Coagulation Factor VII Retrospective Market Scenario by Region
3.1 Global Human Coagulation Factor VII Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Human Coagulation Factor VII Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Human Coagulation Factor VII Market Facts & Figures by Country
3.3.1 North America Human Coagulation Factor VII Sales by Country
3.3.2 North America Human Coagulation Factor VII Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Coagulation Factor VII Market Facts & Figures by Country
3.4.1 Europe Human Coagulation Factor VII Sales by Country
3.4.2 Europe Human Coagulation Factor VII Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Coagulation Factor VII Market Facts & Figures by Region
3.5.1 Asia Pacific Human Coagulation Factor VII Sales by Region
3.5.2 Asia Pacific Human Coagulation Factor VII Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Coagulation Factor VII Market Facts & Figures by Country
3.6.1 Latin America Human Coagulation Factor VII Sales by Country
3.6.2 Latin America Human Coagulation Factor VII Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Coagulation Factor VII Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Coagulation Factor VII Sales by Country
3.7.2 Middle East and Africa Human Coagulation Factor VII Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Coagulation Factor VII Historic Market Analysis by Type
4.1 Global Human Coagulation Factor VII Sales Market Share by Type (2016-2021)
4.2 Global Human Coagulation Factor VII Revenue Market Share by Type (2016-2021)
4.3 Global Human Coagulation Factor VII Price by Type (2016-2021)
5 Global Human Coagulation Factor VII Historic Market Analysis by Application
5.1 Global Human Coagulation Factor VII Sales Market Share by Application (2016-2021)
5.2 Global Human Coagulation Factor VII Revenue Market Share by Application (2016-2021)
5.3 Global Human Coagulation Factor VII Price by Application (2016-2021)
6 Key Companies Profiled
6.1 NovoNordisk
6.1.1 NovoNordisk Corporation Information
6.1.2 NovoNordisk Description and Business Overview
6.1.3 NovoNordisk Human Coagulation Factor VII Sales, Revenue and Gross Margin (2016-2021)
6.1.4 NovoNordisk Human Coagulation Factor VII Product Portfolio
6.1.5 NovoNordisk Recent Developments/Updates
7 Human Coagulation Factor VII Manufacturing Cost Analysis
7.1 Human Coagulation Factor VII Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Coagulation Factor VII
7.4 Human Coagulation Factor VII Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Coagulation Factor VII Distributors List
8.3 Human Coagulation Factor VII Customers
9 Human Coagulation Factor VII Market Dynamics
9.1 Human Coagulation Factor VII Industry Trends
9.2 Human Coagulation Factor VII Growth Drivers
9.3 Human Coagulation Factor VII Market Challenges
9.4 Human Coagulation Factor VII Market Restraints
10 Global Market Forecast
10.1 Human Coagulation Factor VII Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Coagulation Factor VII by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Human Coagulation Factor VII by Type (2022-2029)
10.2 Human Coagulation Factor VII Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Coagulation Factor VII by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Human Coagulation Factor VII by Application (2022-2029)
10.3 Human Coagulation Factor VII Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Coagulation Factor VII by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Human Coagulation Factor VII by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor VII Sales (K Mg) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Human Coagulation Factor VII Sales (K Mg) Comparison by Application (2021-2029)
Table 3. Global Human Coagulation Factor VII Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Human Coagulation Factor VII Covered in This Study
Table 5. Global Human Coagulation Factor VII Sales (K Mg) of Key Manufacturers (2016-2021)
Table 6. Global Human Coagulation Factor VII Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Human Coagulation Factor VII Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Human Coagulation Factor VII Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Human Coagulation Factor VII Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Human Coagulation Factor VII Manufacturing Sites and Area Served
Table 11. Manufacturers Human Coagulation Factor VII Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Coagulation Factor VII by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor VII as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Human Coagulation Factor VII Sales by Region (2016-2021) & (K Mg)
Table 16. Global Human Coagulation Factor VII Sales Market Share by Region (2016-2021)
Table 17. Global Human Coagulation Factor VII Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Human Coagulation Factor VII Sales by Country (2016-2021) & (K Mg)
Table 19. North America Human Coagulation Factor VII Sales Market Share by Country (2016-2021)
Table 20. North America Human Coagulation Factor VII Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Human Coagulation Factor VII Revenue Market Share by Country (2016-2021)
Table 22. Europe Human Coagulation Factor VII Sales by Country (2016-2021) & (K Mg)
Table 23. Europe Human Coagulation Factor VII Sales Market Share by Country (2016-2021)
Table 24. Europe Human Coagulation Factor VII Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Human Coagulation Factor VII Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Human Coagulation Factor VII Sales by Region (2016-2021) & (K Mg)
Table 27. Asia Pacific Human Coagulation Factor VII Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Human Coagulation Factor VII Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Human Coagulation Factor VII Revenue Market Share by Region (2016-2021)
Table 30. Latin America Human Coagulation Factor VII Sales by Country (2016-2021) & (K Mg)
Table 31. Latin America Human Coagulation Factor VII Sales Market Share by Country (2016-2021)
Table 32. Latin America Human Coagulation Factor VII Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Human Coagulation Factor VII Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Human Coagulation Factor VII Sales by Country (2016-2021) & (K Mg)
Table 35. Middle East and Africa Human Coagulation Factor VII Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Human Coagulation Factor VII Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Human Coagulation Factor VII Revenue Market Share by Country (2016-2021)
Table 38. Global Human Coagulation Factor VII Sales (K Mg) by Type (2016-2021)
Table 39. Global Human Coagulation Factor VII Sales Market Share by Type (2016-2021)
Table 40. Global Human Coagulation Factor VII Revenue (Million US$) by Type (2016-2021)
Table 41. Global Human Coagulation Factor VII Revenue Share by Type (2016-2021)
Table 42. Global Human Coagulation Factor VII Price (USD/Kg) by Type (2016-2021)
Table 43. Global Human Coagulation Factor VII Sales (K Mg) by Application (2016-2021)
Table 44. Global Human Coagulation Factor VII Sales Market Share by Application (2016-2021)
Table 45. Global Human Coagulation Factor VII Revenue (Million US$) by Application (2016-2021)
Table 46. Global Human Coagulation Factor VII Revenue Share by Application (2016-2021)
Table 47. Global Human Coagulation Factor VII Price (USD/Kg) by Application (2016-2021)
Table 48. NovoNordisk Corporation Information
Table 49. NovoNordisk Description and Business Overview
Table 50. NovoNordisk Human Coagulation Factor VII Sales (K Mg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. NovoNordisk Human Coagulation Factor VII Product
Table 52. NovoNordisk Recent Developments/Updates
Table 53. Production Base and Market Concentration Rate of Raw Material
Table 54. Key Suppliers of Raw Materials
Table 55. Human Coagulation Factor VII Distributors List
Table 56. Human Coagulation Factor VII Customers List
Table 57. Human Coagulation Factor VII Market Trends
Table 58. Human Coagulation Factor VII Growth Drivers
Table 59. Human Coagulation Factor VII Market Challenges
Table 60. Human Coagulation Factor VII Market Restraints
Table 61. Global Human Coagulation Factor VII Sales Forecast by Type (2022-2029) & (K Mg)
Table 62. Global Human Coagulation Factor VII Sales Market Share Forecast by Type (2022-2029)
Table 63. Global Human Coagulation Factor VII Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 64. Global Human Coagulation Factor VII Revenue Market Share Forecast by Type (2022-2029)
Table 65. Global Human Coagulation Factor VII Sales Forecast by Application (2022-2029) & (K Mg)
Table 66. Global Human Coagulation Factor VII Sales Market Share Forecast by Application (2022-2029)
Table 67. Global Human Coagulation Factor VII Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 68. Global Human Coagulation Factor VII Revenue Market Share Forecast by Application (2022-2029)
Table 69. Global Human Coagulation Factor VII Sales Forecast by Region (2022-2029) & (K Mg)
Table 70. Global Human Coagulation Factor VII Sales Market Share Forecast by Region (2022-2029)
Table 71. Global Human Coagulation Factor VII Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 72. Global Human Coagulation Factor VII Revenue Market Share Forecast by Region (2022-2029)
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Coagulation Factor VII
Figure 2. Global Human Coagulation Factor VII Market Share by Type in 2020 & 2029
Figure 3. Recombinant Factor VIII Product Picture
Figure 4. Plasma-derived Factor VIII Product Picture
Figure 5. Global Human Coagulation Factor VII Market Share by Application in 2020 & 2029
Figure 6. Hemophilia A
Figure 7. Spontanous / Trauma
Figure 8. Surgical
Figure 9. Others
Figure 10. Global Human Coagulation Factor VII Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 11. Global Human Coagulation Factor VII Market Size 2016-2029 (US$ Million)
Figure 12. Global Human Coagulation Factor VII Sales 2016-2029 (K Mg)
Figure 13. Global Human Coagulation Factor VII Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 14. Human Coagulation Factor VII Sales Share by Manufacturers in 2020
Figure 15. Global Human Coagulation Factor VII Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Human Coagulation Factor VII Players: Market Share by Revenue in 2020
Figure 17. Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Human Coagulation Factor VII Sales Market Share by Region (2016-2021)
Figure 19. Global Human Coagulation Factor VII Sales Market Share by Region in 2020
Figure 20. Global Human Coagulation Factor VII Revenue Market Share by Region (2016-2021)
Figure 21. Global Human Coagulation Factor VII Revenue Market Share by Region in 2020
Figure 22. U.S. Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Human Coagulation Factor VII Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Human Coagulation Factor VII by Type (2016-2021)
Figure 47. Sales Market Share of Human Coagulation Factor VII by Application (2016-2021)
Figure 48. Sales Market Share of Human Coagulation Factor VII by Application in 2020
Figure 49. Revenue Share of Human Coagulation Factor VII by Application (2016-2021)
Figure 50. Revenue Share of Human Coagulation Factor VII by Application in 2020
Figure 51. Manufacturing Cost Structure of Human Coagulation Factor VII
Figure 52. Manufacturing Process Analysis of Human Coagulation Factor VII
Figure 53. Human Coagulation Factor VII Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
